Lifetime Risk of ESRD

Lifetime risk of ESRD: a meaningful concept?

Lifetime risk assessment of Radium-226 in drinking water samples

Background: One of the most significant radionuclides in natural drinking waters is 226Ra and its decay products. It is potential of health problems, including cancer risk. In this study, the effect of 226Ra concentration in 28 drinking water samples collected from the North Guilan province was investigated. Materials and Methods: The activity concentrations of 226Ra were measured by using of r...

Beyond Framingham: cardiovascular risk profiling in ESRD.

T hree articles in this issue of JASN describe associations among increased risks of cardiovascular disease and lipoprotein(a) levels and particle size (1), disorders of calcium homeostasis (2), and plasma vitamin C concentrations (3). These reports may occasion the reader to question the relevance of continued observational studies of cardiovascular risk factors, given the well established res...

The impact of losartan on the lifetime incidence of ESRD and costs in Mexico.

BACKGROUND The RENAAL (Reduction of Endpoints in Type 2 Diabetes with the Angiotensin II Antagonist Losartan) study demonstrated that treatment with losartan reduced the risk of ESRD by 29% among hypertensive patients with type 2 diabetes and diabetic nephropathy. The objective of this study was to project the effect of losartan compared to placebo on the lifetime incidence of ESRD and associat...

Standardized lifetime risk.

The authors propose the use of two new standardized measures of risk, the standardized lifetime risk and the standardized number of years of life lost. These measures maintain the advantages of standardized rates but are more readily understood without special training. In this paper, standardizing weights based on 1992 data from England and Wales are provided, and the new measures are illustra...